ArticleBlood2007

Phase 1 and pharmacologic study of MS-275, a histone deacetylase inhibitor, in adults with refractory and relapsed acute leukemias.

Ivana Gojo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.